Efficient and powerful equivalency test on combined mean and variance
  with application to diagnostic device comparison studies by Bai, Yun et al.
ar
X
iv
:1
90
8.
07
97
9v
1 
 [s
tat
.M
E]
  2
1 A
ug
 20
19
Efficient and powerful equivalency test on combined mean
and variance with application to diagnostic device
comparison studies
Yun Bai1, Zengri Wang1, Theodore Lystig1, Baolin Wu2 ∗
1Medtronic plc, Minneapolis, MN, USA
2Division of Biostatistics, School of Public Health, University of Minnesota
Abstract
In medical device comparison studies, equivalency test is commonly used to demonstrate two
measurement methods agree up to a pre-specified performance goal based on the paired repeated
measures. Such equivalency test often involves controlling the absolute differences that depend on
both the mean and variance parameters, and poses some challenges for statistical analysis. For ex-
ample, for the oximetry comparison study that motivates our research, FDA has clear guidelines
approving an investigational pulse oximeter in comparison to a standard oximeter via testing the root
mean squares (RMS), a composite measure of both mean and variance parameters. For the hypoth-
esis testing of this composite measure, existing methods have been either exploratory or relying on
the large-sample normal approximation with conservative and unsatisfactory performance. We de-
velop a novel generalized pivotal test to rigorously and accurately test the system equivalency based
on RMS. The proposed method has well-controlled type I error and favorable performance in our
extensive numerical studies. When analyzing data from an oximetry comparison study, aiming to
demonstrate performance equivalency between an FDA-cleared oximetry system and an investiga-
tional system, our proposed method resulted in a highly significant test result strongly supporting
the system equivalency. We also provide efficient R programs for the proposed method in a publicly
available R package. Considering that many practical equivalency studies of diagnostic devices are
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of small to medium sizes, our proposed method and software timely bridge an existing gap in the
field.
Keywords: Equivalency test; Generalized pivotal quantity; Paired repeated measures; Pulse oximetry
studies
1 Introduction
In medical device comparison studies, equivalency test is commonly used to demonstrate two measure-
ment methods agree up to a pre-specified performance goal based on the paired repeated measures. For
example, for the oximetry comparison study that motivates our research, FDA has clear guidelines on
how to establish the acceptance of a new investigational oximeter in comparison to a standard oxime-
ter through data collection and a formal hypothesis testing framework based on testing the root mean
squares (RMS), which is a composite measure of both mean and variance parameters. However existing
methods are mostly exploratory (Lin, 1989, 1992; Bland and Altman, 1999, 2007) or have relied on the
large-sample normal approximation with conservative and unsatisfactory performance (Pennello, 2002,
2003; Ndikintum and Rao, 2016).
In this paper, we develop statistical methods for the equivalency test problem in the diagnostic device
comparisons. We offer novel insights to the statistical problems with respect to the equivalency test and
provide accurate and efficient solutions for practical use. Specifically we develop powerful statistical
methods with robust statistical properties. The newly developed methods are motivated by the novel
generalized pivotal statistics based approach (Weerahandi, 1995). Through extensive numerical studies,
we demonstrate favorable performance of the proposed methods: they achieve higher power than the
existing methods by a large margin, and can produce accurate confidence intervals to precisely quantify
the variation of key parameter of interest. We further develop a publicly available R package that im-
plements the new methods. Our proposed statistical methods along with the R package provide useful
practical tools to the general community and timely bridge the gap in the field.
The rest of the paper proceeds as follows. Section 2 explains the root mean squares (RMS) testing
problem in a linear random-effects model and our proposed method based on a generalized inference
approach. Next, we study the performance of our method through simulation studies in Section 3 and
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apply the new method to the pulse oximetry data in Section 4. A discussion is given in Section 5.
Throughout the paper, we will mainly focus on intuitive ideas and delegate all technical details to the
Appendix.
2 Statistical methods
Consider a random-effects ANOVA model, Yi j = µ +ui + εi j, i = 1, · · · ,n; j = 1, · · · ,mi, where µ is the
overall mean, the random effects term ui ∼ N(0,σ 2b ) and the random error components εi j ∼ N(0,σ 2w)
are all independent. For paired repeated measure data, Yi j will describe the differences of two measures
(e.g. pulse oximeter measurement and the co-oximeter measurement). Denote Yi = (Yi1, · · · ,Yimi), and
Y = (Y1, · · · ,Yn). We can readily check that Var(Yi j) = σ 2b +σ 2w, Cov(Yi j ,Yik) = σ 2b . Here σ 2b is the
between-level variance, σ 2w is the within-level variance, and µ quantifies the average mean value. This is
a special case of the linear mixed effects model (LMM; Laird and Ware, 1982).
In the following, we use capital letters to denote the random variables, e.g. (Yi j,Yi,Y ), and the
corresponding small letters to denote the observed data, e.g. (yi j,yi,y).
Our main interest is the root mean squares (RMS) parameter defined as ρ =
√
µ2+σ 2b +σ
2
w. In
the paired repeated measure comparison, ρ quantifies the average absolute difference between the two
measures, since E(Y 2i j) = ρ
2. It is of interest to test H0 : ρ ≥ ρ0 versus Ha : ρ < ρ0, where ρ0 is a
pre-specified acceptable threshold. In addition, we want to compute a confidence interval (CI) for ρ to
quantify its variation.
Per the FDA guideline, a pulse oximeter is approvable if the null hypothesis H0 : ρ ≥ ρ0 can be
rejected in favor of the alternative hypothesis Ha : ρ < ρ0 with a pre-specified value ρ0. For example
ρ0 = 3% is often used for transmittance, wrap and clip pulse sensors.
The RMS parameter ρ involves both the mean parameter µ and variance parameters (σ 2b ,σ
2
w). It
poses significant challenges to construct exact methods for inference. To our knowledge, this has not
been well-studied in the filed. Partly owing to the composite nature of ρ and the presence of nuisance pa-
rameters, the large-sample based normal approximation generally does not perform well (Pennello, 2002,
2003; Ndikintum and Rao, 2016). We note that the statistical inference of individual mean and variance
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parameters has been well-studied, and a variety of methods exist (Ting et al., 1990; Zhou and Mathew,
1994; Park and Burdick, 2003; Lee et al., 2004; Park and Burdick, 2004; Iyer et al., 2004; Burdick et al.,
2006). In the following we adopt the method of generalized inference (Tsui and Weerahandi, 1989;
Weerahandi, 1993) to conduct significance test and calculate CI for ρ .
2.1 Generalized test statistic
In the presence of nuisance parameters, the key idea of generalized inference is to construct a gener-
alized pivotal quantity/test statistic, which is defined as a function of observed data, parameters and
random variables. It has a known distribution free of any unknown parameters, and hence can be used to
conduct hypothesis test and calculate CI for the parameter of interest. Compared to the traditional statis-
tical inference based on the pivotal statistic, which is defined as the function of parameters and random
variables with a known distribution, the generalized inference allows the incorporation of observed data.
We refer the reader to the monograph of Weerahandi (1995) for a detailed discussion along with relevant
examples.
Denote the summary statistics, Y¯i = ∑
mi
j=1Yi j/mi, and S
2
i = ∑
mi
j=1(Yi j − Y¯i)2/(mi − 1). We note that
Y¯i ∼ N(µ ,σ 2b +σ 2w/mi) and (mi − 1)S2i ∼ σ 2wχ2mi−1. Here {Y¯i : i = 1, · · · ,n} and {S2i :: i = 1, · · · ,n} are
essentially the sample means and variances, and hence they are independent random variables.
Denote SSE = ∑ni=1(mi − 1)S2i . We have SSE ∼ σ 2wχ2N−n, where N = ∑ni=1mi. Let sse denote the
value of SSE based on the observed data. Define
Qw =
sse
SSE/σ 2w
. (1)
Note that given the observed data, Qw follows a scaled inverse chi-square distribution, and furthermore,
Qw equals to σ
2
w at the observed data, i.e. when SSE takes value sse.
DenoteWi = 1/(σ
2
b +σ
2
w/mi), i= 1, · · · ,n. Let Y¯ =∑ni=1WiY¯i/(∑ni=1Wi). We note that Y¯i ∼N(µ ,W−1i ),
and Y¯ ∼ N(µ ,1/(∑ni=1Wi)). Treating Y¯i as the outcomes regressed onto a constant with weight Wi, and
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based on the standard linear regression theory, we can check that
SSR =
n
∑
i=1
Wi(Y¯i− Y¯ )2 =
n
∑
i=1
Y¯ 2i
σ 2b +σ
2
w/mi
− [∑
n
i=1 Y¯i/(σ
2
b +σ
2
w/mi)]
2
∑ni=1(σ
2
b +σ
2
w/mi)
−1 , (2)
is a χ2n−1 random variable. Furthermore Y¯ and SSR are independent. Based on equation (2), we can solve
σ 2b as a deterministic function of (Y¯ ,σ
2
w,SSR), denoted as h(Y¯ ,σ
2
w,SSR). Here Y¯ = (Y¯1, · · · ,Y¯n). Define
a generalized test statistic
Qb = h(y¯,Qw,SSR), (3)
where y¯=(y¯1, · · · , y¯n) denote the observed sample means. Given the observed data, both the distributions
of Qw and SSR are known, hence Qb has a distribution free of any parameters, and Qb equals to σ
2
b at the
observed data.
Denote Z = (Y¯ −µ)√∑ni=1Wi. We have Z ∼N(0,1). Therefore, we can write µ = Y¯ −Z/√∑ni=1Wi
(Iyer et al., 2004). Define the following generalized test statistic
Qµ =
[
y˜−Z
( n
∑
i=1
W˜i
)−1/2]2
, W˜i =
1
Qb +Qw/mi
, y˜ =
∑ni=1 y¯iW˜i
∑ni=1W˜i
. (4)
Given the observed data, Qµ has a known distribution free of any parameters. Furthermore, at the ob-
served data, Qb and Qw reduce to σ
2
b and σ
2
w, and hence Qµ equals µ
2.
2.2 Generalized test p-value and generalized CI calculation
For inference on the RMS parameter ρ , we consider the following generalized test statistic,
Q = Qw +Qb +Qµ . (5)
We treat those observed quantities, e.g. (y¯,sse), as constants, and the distribution of Q is induced by
(SSE,SSR,Z). We note that the generalized test statistic Q and its distribution require only the summary
statistics: sse and y¯. It is clear that the distribution of Q does not depend on any unknown parameters
given the observed data. We also note that for the observed data, Q reduces to ρ2 = σ 2w +σ
2
b + µ
2.
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The generalized p-value for testing H0 : ρ ≥ ρ0 can be computed as Pr(Q ≥ ρ20 ), and a 100(1−α)%
generalized CI for ρ can be computed as [
√
Q(α/2),
√
Q(1−α/2)], where Q(α) denotes the α-th percentile
of the distribution of Q (Tsui and Weerahandi, 1989; Weerahandi, 1993).
Following the generalized test literature, the statistical inference can be made based on generating
random numbers from the distribution of Q as follows:
(i) simulate (SSE/σ 2w) from the χ
2
N−n distribution to generate Qw;
(ii) simulate SSR from the χ2n−1 distribution, and compute Qb from Qw and SSR;
(iii) simulate Z from N(0,1) distribution, and compute Qµ from Qw, Qb and Z;
(iv) compute Q = Qw +Qb +Qµ .
Given the simulated random realizations, denoted as (Q1, · · · ,QB), we compute the generalized test
p-value for testing H0 : ρ ≥ ρ0
P =
∑Bi=1 I(Q
i ≥ ρ20 )
B
, (6)
and compute the generalized CI for ρ with 1−α coefficient as
[√
Q(Bα/2),
√
Q(B(1−α/2))
]
, (7)
where Q(k) denotes the ordered Q-values.
2.3 Numerical computation
Note that conditional on the Qw and Qb,
√
Qµ follows a normal distribution with mean y˜ and variance
1/(∑iW˜i). Hence we can easily compute Pr(Q ≥ ρ20 |Qw,Qb) = Sχ21 [(∑iW˜i)(ρ
2
0 −Qw −Qb)|y˜2(∑iW˜i)],
where Sχ21
(·|λ ) denotes the tail probability of a χ21 distribution with non-centrality parameter λ . There-
fore we can compute the generalized test p-value as
P =
1
B
B
∑
k=1
Pr(Q ≥ ρ20 |Qkw,Qkb).
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The corresponding generalized CI can be computed by reversely solving the critical values of Q at the
generalized p-values of α/2 and (1−α/2). We note that this practice amounts to analytically integrating
out the random variable Z from the marginal distribution of Q, which avoids the need for actual Monte
Carlo simulation of Z and can lead to more accurate test p-value and CI calculation.
2.4 Large-sample normal approximation
The existing large-sample test methods are based on the normal approximation of R = ∑i, j Y
2
i j/N with
mean and variance (Pennello, 2002, 2003; Ndikintum and Rao, 2016)
E(R) = ρ2, Var(R) =
2
N2
n
∑
i=1
(σ 2w +miσ
2
b )
2+(mi−1)σ 4w +2mi(σ 2w +miσ 2b )µ2. (8)
The parameter estimates can be readily obtained from fitting a LMM to the data. The existing methods
differ in their calculation of the variance, leading to a score test and Wald test, denoted as Z-score and
Z-Wald respectively, depending on whether the variance is computed under the null hypothesis or not.
In the next section we conduct simulation studies to investigate the performance of proposed method
(with B = 104, denoted as GT) compared to the existing large-sample test methods.
3 Numerical studies
In the numerical studies, we have found that the Z-Wald test has very liberal type I errors (the complete
results are available at the Supporting Information Section S1). Hence we only include the Z-score test
in the following comparison.
We conducted two sets of simulations. First, we simulate an unbalanced study with parameters,
(µ = −0.57,σw = 1.48,σb = 1.38), estimated from a pulse oximetry comparison study (see Section 4).
We consider n = 16 subjects with mi ranging from 5 to 20, and n = 20 subjects with mi ranging from 5
to 24. We set ρ0 = 2.1 under the null hypothesis and ρ0 = 3 for estimating power. Secondly, we consider
a balanced study with combinations of n = (10,20,30), m = (5,10,20), σ 2w +σ
2
b = (0.2,0.4,0.8)×ρ2,
σ 2w/σ
2
b = (1/3,1,3), and setting µ =
√
ρ2−σ 2w−σ 2b . We test H0 : ρ ≥ 3, and set ρ = 3 under the null
hypothesis and ρ =
√
6 for estimating power.
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3.1 Type I errors
We conduct 104 null simulations to evaluate the type I errors at the significance level α = 0.01 and
0.05. Overall we have obtained very similar patterns across all simulation scenarios. Here we present the
results for the unbalanced study and the balanced study with n = 20,m = 10. The complete simulation
results can be found in the Supporting Information Section S1.
Table 1 summarizes the empirical type I errors for the unbalanced study with n = 16,20 subjects.
Table 2 shows the empirical type I errors for balanced study with (σ 2w +σ
2
b )/ρ
2 = (0.2,0.4,0.8) and
σ 2w/σ
2
b = (1/3,1,3) at α = 0.05,0.01. The proposed test (denoted as GT) is compared to the Z-score
test. Overall the results show that the type I errors are well controlled for the proposed method, while the
Z-score test is more conservative especially at more stringent significance level. For the proposed GT,
generally larger µ (smaller σ 2w +σ
2
b ) leads to more accurate control of type I errors.
Table 1: Empirical type I errors at significance level α estimated over 104 simulations. GT is the
proposed test, Z-score is the score based Z-test. Data are simulated from n subjects with parameters
(µ =−0.57,σw = 1.48,σb = 1.38).
n = 16 n = 20
α 0.05 0.01 0.05 0.01
GT 0.028 0.005 0.032 0.006
Z-score 0.023 0.0003 0.026 0.0004
Table 2: Empirical type I errors at significance level α estimated over 104 null simulations. Data are
simulated from n = 20 subjects each with m = 10 measures and ρ = 3. GT is the proposed test, Z-score
is the score based Z-test.
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 0.041 0.047 0.045 0.040 0.045 0.039 0.030 0.034 0.033
Z-score 0.034 0.041 0.039 0.033 0.039 0.036 0.026 0.032 0.032
α = 0.01
GT 0.0073 0.0079 0.0100 0.0083 0.0090 0.0077 0.0056 0.0063 0.0059
Z-score 0.0019 0.0033 0.0050 0.0019 0.0024 0.0026 0.0007 0.0009 0.0027
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3.2 Power
For the unbalanced study, we consider testing H0 : ρ > 3. For the balanced study, we set ρ0 =
√
6
and consider testing H0 : ρ > 3. We use 10
4 Monte Carlo simulations to estimate power under each
configuration. Overall, we have observed very similar conclusions across simulation scenarios. Here we
report the results for the unbalanced study and balanced study with n = 20,m = 10. The complete results
are available at the Supporting Information Section S1.
Table S6 summarizes the power for the unbalanced study. Table 4 summarizes the power for (σ 2w +
σ 2b )/6 = (0.2,0.8) and σ
2
w/σ
2
b = (1/3,3) under the 0.01 and 0.05 significance levels. Overall the pro-
posed method performs remarkably better than the Z-score test by a large margin, especially at more
stringent significance level. For the proposed GT, (1) smaller between-subject variance σ 2b leads to
higher power; and (2) larger µ (smaller σ 2w +σ
2
b ) also leads to higher power.
Table 3: Power (%) at significance level α estimated over 104 simulations. GT is the proposed test,
Z-score is the score based Z-test. Data are simulated from n subjects with parameters (µ =−0.57,σw =
1.48,σb = 1.38). We are testing H0 : ρ ≥ 3.
n = 16 n = 20
α 0.05 0.01 0.05 0.01
GT 82.1 49.3 92.7 68.2
Z-score 72.1 3.2 86.2 16.6
Table 4: Power (%) at significance level α estimated over 104 simulations. Data are simulated for n = 20
subjects each with m = 10 measures under σ 2w +σ
2
b + µ
2 = 6. We are testing H0 : ρ ≥ 3. GT is the
proposed test, and Z-score is the score based Z-test.
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 75.4 88.0 98.2 51.2 66.2 87.8 33.0 48.1 73.2
Z-score 72.1 85.9 97.7 46.5 62.2 86.2 30.5 45.0 71.6
α = 0.01
GT 44.7 62.8 89.0 21.2 34.1 61.4 11.0 19.5 41.0
Z-score 25.9 43.4 78.5 7.6 16.2 41.7 2.4 5.5 18.9
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3.3 CI calculation
Table 5 and S9 summarize the coverage probability (CP) and average width (AW) of computed 90% CIs
over 104 simulations. Overall we can see that the CIs produced by the proposed method (denoted as
GCI) have very good coverage probability close to the nominal 90% level. As expected, the Z-score test
based approach has more conservative performance, with CP generally much larger than the desired 90%
level and CI much wider than the GCI.
Table 5: Coverage probability (CP) and average width (AW) of 90% CI for ρ estimated over 104 simula-
tions. GCI is the proposed test, Z-score is the score based Z-test. Data are simulated from an unbalanced
study with n subjects and ρ = 2.1.
n = 16 n = 20
CP AW CP AW
GCI 0.892 0.815 0.891 0.693
Z-score 0.973 0.836 0.965 0.728
Table 6: Coverage probability (CP) and average width (AW) of 90% CI estimated over 104 simulations.
Data are simulated from a balanced study with n = 20 subjects each with m = 10 measures and ρ = 3.
GCI is the proposed test, Z-score is the score based Z-test.
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
CP
GCI 0.899 0.898 0.902 0.900 0.896 0.895 0.890 0.892 0.896
Z-score 0.933 0.929 0.923 0.951 0.939 0.929 0.963 0.963 0.953
AW
GCI 0.841 0.701 0.535 1.109 0.909 0.687 1.357 1.055 0.761
Z-score 0.874 0.720 0.539 1.187 0.956 0.707 1.450 1.091 0.772
4 Application to oximetry comparison study
For illustration, we consider an oximetry comparison study conducted by a medical device company
to demonstrate equivalency in performance between an FDA-cleared oximetry system and an investi-
gational oximeter. The study has obtained multiple measures of difference of tissue oxygen saturation
levels for a cohort of healthy, non-smoking adults and adolescent volunteers. We model the measured
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oxygen differences with a linear mixed-effects model (LMM), and investigate the system equivalency
based on testing H0 : ρ ≥ 3%.
For illustrative purposes, we analyze a representative dataset from 16 individuals and provide the
summary data. Table 7 listed the sample size mi and mean y¯i for each individual. The observed sse =
221.037%2. We note that the LMM estimation requires only (y¯,sse) without the need of individual level
data, similar to the proposed generalized test method (see Appendix for details).
Table 7: Individual sample sizes and means (%) for the oximetry comparison study
Individual i mi y¯i Individual i mi y¯i
1 9 -0.026 9 10 0.963
2 10 0.447 10 10 0.643
3 10 0.083 11 10 -0.200
4 10 -0.103 12 10 -1.337
5 5 -2.587 13 2 -4.333
6 10 -0.610 14 10 -2.807
7 10 0.040 15 10 0.563
8 10 -0.593 16 10 -0.797
The proposed GT (using B = 104 simulations) yields a significant p-value of 0.006, and the computed
90% GCI for the RMS parameter ρ is [1.665,2.528]%. The Z-score test reported a p-value of 0.010 with
computed 90% CI for ρ2 as [-1.447, 7.221]%2, leading to a 90% CI for ρ as [0,2.687]% for ρ . Both tests
supported equivalency of the two systems. The proposed test produced a more significant test p-value
and a much narrower CI, offering stronger support for the system equivalency.
5 Discussion
We have proposed a generalized significance test method with accurate CI calculation for the root mean
squares parameter (RMS) in a linear mixed-effects model. The RMS parameter directly quantifies the
total absolute variation of outcomes and can be used to test equivalency in paired medical device com-
parison studies. Compared to the existing large-sample test methods, our proposed method shows more
powerful performance and produces CIs with more accurate coverage probabilities. When applied to a
pulse oximetry equivalency study, our proposed method yielded more signifiant test p-value and stronger
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evidence to support the system equivalency, as compared to the existing methods. We have also con-
ducted extensive numerical studies to illustrate the very favorable performance of our proposed method.
The new approach has been implemented in a publicly available R package. The new method along with
the R package provide useful and practical tools, and timely bridge an existing gap in the field.
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A Sufficient statistics, likelihood calculation, and parameter estimation
Denote Σi = Cov(Yi) for i = 1, · · · ,n. We can write Σi = σ 2b1mi1Tmi +σ 2wImi , with 1mi being a column
vector of ones and Imi an mi-th oder identity matrix. Noting that 1mi1
T
mi
/mi is a rank-one projection
matrix, Σi has two unique eigenvalues: σ
2
w (with algebraic multiplicity mi − 1) and σ 2w +miσ 2b (with
algebraic multiplicity 1). We can analytically compute its inverse and determinant, and check that
−2log[Pr(yi)] ∝ log(σ 2w +miσ 2b )+ (mi − 1) log(σ 2w)+σ−2w ‖yi − y¯i‖2+(σ 2w +miσ 2b )−1mi(y¯i − µ)2 (up
to some constant that does not depend on data). The log likelihood can then be shown proportional to
(N−n) log(σ 2w)+
sse
σ 2w
+
n
∑
i=1
{
log(σ 2w +miσ
2
b )+
mi(y¯i−µ)2
σ 2w +miσ
2
b
}
,
where sse = ∑i‖yi− y¯i‖2. Therefore, we just need (y¯,sse) to compute likelihood to estimate parameters,
the same as the proposed generalized test method, as shown previously.
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Supporting Information
S1 Simulation study
We conducted two sets of simulations. First, we simulate an unbalanced study with parameters, (µ =
−0.57,σw = 1.48,σb = 1.38), estimated from a pulse oximetry comparison study (see main text Section
4). We consider n= 16 subjects with mi ranging from 5 to 20, and n = 20 subjects with mi ranging from 5
to 24. We set ρ0 = 2.1 under the null hypothesis and ρ0 = 3 for estimating power. Secondly, we consider
a balanced study with combinations of n = (10,20,30), m = (5,10,20), σ 2w +σ
2
b = (0.2,0.4,0.8)×ρ2,
σ 2w/σ
2
b = (1/3,1,3), and setting µ =
√
ρ2−σ 2w−σ 2b . We test H0 : ρ ≥ 3, and set ρ = 3 under the null
hypothesis and ρ =
√
6 for estimating power. The proposed test (denoted as GT) is compared to the
Z-score/Z-Wald tests.
The main text contains the simulation results for the unbalanced studies. Here we summarize the
complete simulation results for the balanced studies.
S1.1 Type I errors
We conduct 104 null simulations to evaluate the type I errors at the significance level α = 0.01 and 0.05.
Tables S1-S3 summarize the type I errors for the balanced studies. Overall we have obtained very similar
patterns across all simulation scenarios. The type I errors are well controlled for the proposed method.
The Z-score test is more conservative especially at more stringent significance level, and the Z-Wald test
has severely inflated type I errors. The Z-score test has largely improved performance with increasing
sample sizes. In contrast, the GT has relatively stable performance across all scenarios. Overall, larger
µ (smaller σ 2w +σ
2
b ) leads to more accurate control of type I errors for the proposed GT.
15
Table S1: Empirical type I errors at significance level α estimated over 104 null simulations. Data are
simulated from n = 10 subjects each with m measures and ρ = 3. GT is the proposed test, Z-score is the
score based Z-test.
n = 10,m = 5
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 0.043 0.043 0.040 0.040 0.037 0.030 0.026 0.024 0.017
Z-score 0.027 0.031 0.034 0.024 0.026 0.026 0.016 0.021 0.025
Z-Wald 0.110 0.106 0.096 0.137 0.124 0.110 0.143 0.136 0.115
α = 0.01
GT 0.0082 0.0082 0.0063 0.0072 0.0076 0.0045 0.0048 0.0043 0.0025
Z-score 0.0001 0.0002 0.0007 0 0.0001 0.0003 0 0.0001 0.0002
Z-Wald 0.056 0.050 0.042 0.072 0.066 0.052 0.083 0.078 0.054
n = 10,m = 10
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 0.042 0.040 0.041 0.036 0.038 0.036 0.026 0.025 0.024
Z-score 0.029 0.027 0.030 0.022 0.023 0.029 0.016 0.017 0.025
Z-Wald 0.109 0.102 0.093 0.122 0.123 0.104 0.153 0.142 0.116
α = 0.01
GT 0.0083 0.0068 0.0072 0.0075 0.0079 0.0074 0.0050 0.0038 0.0027
Z-score 0.0006 0.0001 0.0007 0 0 0.0004 0 0 0.0003
Z-Wald 0.051 0.046 0.039 0.066 0.063 0.049 0.085 0.078 0.056
n = 10,m = 20
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 0.043 0.044 0.046 0.036 0.042 0.039 0.030 0.027 0.029
Z-score 0.027 0.030 0.033 0.023 0.027 0.027 0.017 0.018 0.023
Z-Wald 0.110 0.105 0.094 0.131 0.127 0.105 0.157 0.141 0.124
α = 0.01
GT 0.0074 0.0085 0.0091 0.0082 0.0079 0.0078 0.0057 0.0060 0.0052
Z-score 0 0.0006 0.0002 0 0 0.0001 0 0.0001 0.0001
Z-Wald 0.055 0.047 0.041 0.068 0.065 0.048 0.094 0.081 0.061
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Table S2: Empirical type I errors at significance level α estimated over 104 null simulations. Data are
simulated from n = 20 subjects each with m measures and ρ = 3. GT is the proposed test, Z-score is the
score based Z-test.
n = 20,m = 5
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 0.046 0.044 0.045 0.043 0.042 0.040 0.033 0.030 0.029
Z-score 0.038 0.038 0.042 0.033 0.036 0.039 0.031 0.031 0.037
Z-Wald 0.091 0.085 0.081 0.103 0.097 0.090 0.120 0.111 0.101
α = 0.01
GT 0.0079 0.0086 0.0089 0.0079 0.0078 0.0078 0.0055 0.0057 0.0039
Z-score 0.0029 0.0046 0.0044 0.0019 0.0020 0.0026 0.0010 0.0008 0.0019
Z-Wald 0.037 0.033 0.031 0.047 0.043 0.037 0.060 0.054 0.043
n = 20,m = 10
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 0.041 0.047 0.045 0.040 0.045 0.039 0.030 0.034 0.033
Z-score 0.034 0.041 0.039 0.033 0.039 0.036 0.026 0.032 0.032
Z-Wald 0.084 0.089 0.079 0.103 0.099 0.082 0.118 0.118 0.099
α = 0.01
GT 0.0073 0.0079 0.0100 0.0083 0.0090 0.0077 0.0056 0.0063 0.0059
Z-score 0.0019 0.0033 0.0050 0.0019 0.0024 0.0026 0.0007 0.0009 0.0027
Z-Wald 0.032 0.033 0.028 0.044 0.045 0.033 0.057 0.056 0.041
n = 20,m = 20
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 0.047 0.047 0.044 0.042 0.044 0.045 0.034 0.034 0.035
Z-score 0.040 0.041 0.038 0.034 0.037 0.040 0.031 0.029 0.035
Z-Wald 0.090 0.084 0.076 0.100 0.100 0.0915 0.120 0.117 0.105
α = 0.01
GT 0.0090 0.0092 0.0095 0.0077 0.0073 0.0100 0.0066 0.0052 0.0063
Z-score 0.0032 0.0029 0.0043 0.0017 0.0022 0.0039 0.0007 0.0005 0.0020
Z-Wald 0.038 0.032 0.025 0.045 0.042 0.035 0.064 0.057 0.046
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Table S3: Empirical type I errors at significance level α estimated over 104 null simulations. Data are
simulated from n = 30 subjects each with m measures and ρ = 3. GT is the proposed test, Z-score is the
score based Z-test.
n = 30,m = 5
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 0.047 0.047 0.048 0.039 0.046 0.039 0.036 0.035 0.031
Z-score 0.042 0.042 0.045 0.034 0.042 0.038 0.035 0.036 0.039
Z-Wald 0.082 0.081 0.075 0.089 0.090 0.079 0.105 0.103 0.091
α = 0.01
GT 0.0087 0.0098 0.0097 0.0078 0.0095 0.0074 0.0073 0.0060 0.0048
Z-score 0.0040 0.0051 0.0059 0.0030 0.0043 0.0042 0.0016 0.0019 0.0024
Z-Wald 0.030 0.028 0.027 0.034 0.037 0.027 0.050 0.045 0.034
n = 30,m = 10
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 0.045 0.045 0.047 0.048 0.044 0.044 0.037 0.036 0.038
Z-score 0.040 0.041 0.044 0.042 0.039 0.041 0.035 0.035 0.041
Z-Wald 0.081 0.073 0.071 0.097 0.090 0.079 0.106 0.103 0.092
α = 0.01
GT 0.0083 0.0095 0.0085 0.0096 0.0089 0.0083 0.0060 0.0059 0.0062
Z-score 0.0037 0.0055 0.0046 0.0031 0.0036 0.0038 0.0016 0.0022 0.0029
Z-Wald 0.029 0.027 0.023 0.042 0.035 0.026 0.052 0.044 0.036
n = 30,m = 20
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 0.048 0.049 0.044 0.040 0.044 0.042 0.035 0.034 0.038
Z-score 0.044 0.044 0.041 0.035 0.039 0.039 0.033 0.033 0.038
Z-Wald 0.086 0.079 0.068 0.092 0.073 0.108 0.103 0.094 0.105
α = 0.01
GT 0.0110 0.0099 0.0074 0.0082 0.0084 0.0079 0.0065 0.0073 0.0055
Z-score 0.0053 0.0042 0.0042 0.0031 0.0029 0.0033 0.0022 0.0027 0.0023
Z-Wald 0.031 0.028 0.020 0.035 0.034 0.027 0.050 0.044 0.038
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S1.2 Power
For the unbalanced study, we consider testing H0 : ρ > 3. For the balanced study, we set ρ0 =
√
6
and consider testing H0 : ρ > 3. We use 10
4 Monte Carlo simulations to estimate power under each
configuration. Tables S4-S6 summarize the power. Overall, we have observed very similar conclusions
across simulation scenarios. The proposed GT performs better than the Z-score test by a large margin.
For the proposed GT, (1) smaller between-subject variance σ 2b leads to larger power; and (2) larger µ
(smaller σ 2w +σ
2
b ) also leads to larger power.
Table S4: Power (%) at significance level α estimated over 104 simulations. Data are simulated for
n = 10 subjects each with m measures under σ 2w +σ
2
b + µ
2 = 6. We are testing H0 : ρ ≥ 3. GT is the
proposed test, and Z-score is the score based Z-test.
n = 10,m = 5
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 42.7 53.2 68.7 25.6 31.1 44.3 14.7 18.9 26.0
Z-score 33.2 43.7 61.7 17.5 23.2 37.3 9.7 14.0 23.8
α = 0.01
GT 15.0 21.5 33.9 7.1 9.5 16.4 3.3 5.1 6.8
Z-score 0.5 0.9 3.0 0 0.1 0.6 0 0 0.2
n = 10,m = 10
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 43.5 57.2 79.0 25.9 34.9 54.2 15.1 21.4 36.1
Z-score 33.9 47.7 71.8 18.0 25.6 44.9 9.6 15.2 29.1
α = 0.01
GT 15.4 24.2 44.7 7.6 11.4 22.2 3.6 5.7 11.9
Z-score 0.5 1.3 5.5 0.1 0.1 0.7 0 0 0.1
n = 10,m = 20
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 44.7 59.4 83.8 26.5 36.9 60.5 15.9 23.5 44.0
Z-score 34.7 49.5 76.8 18.3 27.3 50.8 10.4 15.8 33.8
α = 0.01
GT 16.6 26.0 51.3 7.6 12.4 26.8 3.7 6.3 15.6
Z-score 0.5 1.7 7.1 0 0.2 1.0 0 0 0.1
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Table S5: Power (%) at significance level α estimated over 104 simulations. Data are simulated for
n = 20 subjects each with m measures under σ 2w +σ
2
b + µ
2 = 6. We are testing H0 : ρ ≥ 3. GT is the
proposed test, and Z-score is the score based Z-test.
n = 20,m = 5
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 74.6 84.9 95.6 49.6 61.3 78.9 32.0 42.6 60.7
Z-score 71.1 82.5 95.0 45.4 57.6 76.8 29.6 40.6 61.1
α = 0.01
GT 43.0 58.3 80.4 21.6 30.3 49.0 10.3 16.1 28.4
Z-score 24.3 38.7 65.4 7.9 14.1 30.2 2.5 4.6 13.1
n = 20,m = 10
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 75.4 88.0 98.2 51.2 66.2 87.8 33.0 48.1 73.2
Z-score 72.1 85.9 97.7 46.5 62.2 86.2 30.5 45.0 71.6
α = 0.01
GT 44.7 62.8 89.0 21.2 34.1 61.4 11.0 19.5 41.0
Z-score 25.9 43.4 78.5 7.6 16.2 41.7 2.4 5.5 18.9
n = 20,m = 20
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 77.1 90.0 99.4 51.5 69.2 91.8 33.7 50.6 81.4
Z-score 74.1 88.0 99.2 47.2 65.3 90.1 31.1 47.2 79.1
α = 0.01
GT 46.4 66.7 93.2 22.4 36.9 69.3 11.3 21.4 51.4
Z-score 26.9 46.9 84.7 8.4 17.3 49.3 2.4 5.9 25.2
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Table S6: Power (%) at significance level α estimated over 104 simulations. Data are simulated for
n = 30 subjects each with m measures under σ 2w +σ
2
b + µ
2 = 6. We are testing H0 : ρ ≥ 3. GT is the
proposed test, and Z-score is the score based Z-test.
n = 30,m = 5
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 90.0 96.4 99.5 68.1 80.5 93.5 47.0 61.8 80.2
Z-score 88.5 95.9 99.4 65.6 78.8 93.1 45.8 61.0 80.2
α = 0.01
GT 67.4 83.3 96.0 37.0 52.7 75.3 19.3 30.9 51.1
Z-score 55.0 74.2 93.1 23.1 38.0 64.1 9.0 17.8 37.8
n = 30,m = 10
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 90.7 97.4 99.95 68.8 84.2 97.2 49.0 67.2 91.1
Z-score 89.5 97.1 99.95 66.2 82.5 96.8 47.5 65.9 90.7
α = 0.01
GT 68.7 86.7 98.8 39.1 57.9 85.7 20.6 35.8 68.9
Z-score 56.7 79.1 97.5 24.8 42.8 77.2 10.0 19.8 53.1
n = 30,m = 20
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
α = 0.05
GT 91.8 97.9 99.98 70.3 86.2 98.6 49.5 71.1 95.0
Z-score 90.6 97.6 99.96 67.7 84.6 98.3 47.5 69.3 94.5
α = 0.01
GT 71.3 88.3 99.5 39.1 60.0 91.2 21.2 40.4 77.7
Z-score 59.3 81.1 98.9 25.4 45.6 84.5 10.1 23.2 61.9
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S1.3 CI calculation
Table S7-S9 summarize the coverage probability (CP) and average width (AW) of computed 90% CIs
over 104 simulations. Overall we can see that the CIs produced by the proposed method (denoted as
GCI) have very good coverage probability close to the nominal 90% level. As expected, the Z-score test
based approach has more conservative performance, with CP generally much larger than the desired 90%
level and CI much wider than the GCI.
Table S7: Coverage probability (CP) and average width (AW) of 90% CI estimated over 104 simulations.
Data are simulated from a balanced study with n = 20 subjects each with m = 10 measures and ρ = 3.
GCI is the proposed test, Z-score is the score based Z-test.
n = 20,m = 5
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
CP
GCI 0.891 0.892 0.905 0.885 0.889 0.897 0.874 0.881 0.878
Z-score 0.939 0.934 0.935 0.958 0.950 0.947 0.980 0.975 0.965
AW
GCI 1.259 1.080 0.891 1.689 1.427 1.170 2.209 1.804 1.437
Z-score 1.324 1.109 0.888 1.873 1.523 1.200 2.373 1.828 1.393
n = 20,m = 10
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
CP
GCI 0.895 0.892 0.893 0.888 0.889 0.895 0.883 0.882 0.883
Z-score 0.941 0.933 0.921 0.958 0.953 0.944 0.981 0.976 0.964
AW
GCI 1.242 1.036 0.791 1.655 1.354 1.020 2.134 1.660 1.195
Z-score 1.297 1.056 0.783 1.827 1.428 1.036 2.287 1.653 1.144
n = 20,m = 20
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
CP
GCI 0.893 0.901 0.902 0.888 0.890 0.898 0.885 0.884 0.884
Z-score 0.939 0.939 0.927 0.959 0.953 0.941 0.981 0.979 0.964
AW
GCI 1.229 1.006 0.741 1.635 1.309 0.946 2.115 1.591 1.064
Z-score 1.282 1.020 0.731 1.803 1.382 0.952 2.250 1.575 1.008
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Table S8: Coverage probability (CP) and average width (AW) of 90% CI estimated over 104 simulations.
Data are simulated from a balanced study with n = 20 subjects each with m = 10 measures and ρ = 3.
GCI is the proposed test, Z-score is the score based Z-test.
n = 20,m = 5
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
CP
GCI 0.899 0.896 0.900 0.898 0.898 0.900 0.885 0.885 0.890
Z-score 0.933 0.928 0.922 0.948 0.943 0.936 0.963 0.962 0.952
AW
GCI 0.852 0.734 0.600 1.125 0.958 0.779 1.391 1.139 0.911
Z-score 0.887 0.756 0.608 1.212 1.013 0.805 1.496 1.184 0.927
n = 20,m = 10
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
CP
GCI 0.899 0.898 0.902 0.900 0.896 0.895 0.890 0.892 0.896
Z-score 0.933 0.929 0.923 0.951 0.939 0.929 0.963 0.963 0.953
AW
GCI 0.841 0.701 0.535 1.109 0.909 0.687 1.357 1.055 0.761
Z-score 0.874 0.720 0.539 1.187 0.956 0.707 1.450 1.091 0.772
n = 20,m = 20
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
CP
GCI 0.902 0.901 0.896 0.900 0.890 0.900 0.892 0.893 0.894
Z-score 0.936 0.928 0.918 0.948 0.937 0.933 0.964 0.961 0.952
AW
GCI 0.835 0.684 0.501 1.093 0.881 0.636 1.336 1.008 0.677
Z-score 0.866 0.699 0.504 1.172 0.925 0.652 1.425 1.044 0.686
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Table S9: Coverage probability (CP) and average width (AW) of 90% CI estimated over 104 simulations.
Data are simulated from a balanced study with n = 30 subjects each with m = 10 measures and ρ = 3.
GCI is the proposed test, Z-score is the score based Z-test.
n = 30,m = 5
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
CP
GCI 0.897 0.900 0.902 0.894 0.896 0.896 0.891 0.890 0.892
Z-score 0.925 0.926 0.921 0.937 0.935 0.928 0.957 0.955 0.943
AW
GCI 0.690 0.592 0.483 0.908 0.772 0.627 1.101 0.900 0.720
Z-score 0.715 0.608 0.490 0.966 0.810 0.649 1.174 0.941 0.740
n = 30,m = 10
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
CP
GCI 0.899 0.901 0.903 0.899 0.892 0.895 0.893 0.890 0.895
Z-score 0.925 0.924 0.920 0.940 0.928 0.925 0.954 0.950 0.943
AW
GCI 0.678 0.565 0.433 0.891 0.730 0.554 1.074 0.835 0.603
Z-score 0.701 0.579 0.438 0.945 0.765 0.570 1.140 0.870 0.618
n = 30,m = 20
(σ 2w +σ
2
b )/ρ
2 0.2 0.4 0.8
σ 2w : σ
2
b 1:3 1:1 3:1 1:3 1:1 3:1 1:3 1:1 3:1
CP
GCI 0.899 0.893 0.900 0.897 0.894 0.899 0.890 0.893 0.898
Z-score 0.930 0.921 0.917 0.940 0.931 0.928 0.954 0.954 0.947
AW
GCI 0.673 0.550 0.404 0.883 0.710 0.512 1.058 0.798 0.537
Z-score 0.695 0.563 0.408 0.936 0.742 0.526 1.125 0.831 0.550
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S2 R package
The following are some sample codes to install and use the ‘RAMgt’ R package.
## install/load the package
library(RAMgt)
## Simulation example: how to get summary stats from data
A = rep(1:10, 5:14)
Y = 0.5+rnorm(length(A))+rnorm(length(unique(A)))[A]
ng = as.vector(table(A))
sse = sum(tapply(Y, A, var)*(ng-1), na.rm=TRUE)
mus = tapply(Y, A, mean)
GTrms(ng,mus,sse, alpha=0.05,rho0=2.5)
## Z-test
Zrms(ng,mus,sse, alpha=0.05,rho0=2.5)
The oximetry comparison data can be analyzed to reproduce the analysis results reported in the main
paper.
## PO comparison study
ng = c(9, 10, 10, 10, 5, 10, 10, 10, 10, 10, 10, 10, 2, 10, 10, 10)
mus = c(-0.026,0.447,0.083,-0.103,-2.587,-0.61,0.04,-0.593, 0.963,0.643,
-0.2,-1.337,-4.333,-2.807,0.563,-0.797)
sse = 221.037
set.seed(123)
GTrms(ng,mus,sse, alpha=0.1, rho0=3, Bmc=1e4)
## Z-test
Zrms(ng,mus,sse, alpha=0.1,rho0=3)
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